SCHEMBL21920738

SCHEMBL21920738

CS(=O)(=O)Nc1cc(C#N)cc2cc[nH]c12

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ NR3C1 P04150 3/20 0.56
▸ NR3C2 P08235 2/20 0.56
▸ PGR P06401 1/20 0.56
▸ AR P10275 1/20 0.56
▸ PARP14 Q460N5 1/20 0.43
▸ SLC22A12 Q96S37 2/20 0.41
▸ IKBKB O14920 2/20 0.41
▸ CHUK O15111 2/20 0.41
▸ XDH P47989 1/20 0.41
▸ IMPDH2 P12268 1/20 0.41
▸ IMPDH1 P20839 1/20 0.41
▸ ATIC P31939 2/20 0.39
▸ BRD4 O60885 2/20 0.38
▸ RIPK1 Q13546 1/20 0.37
▸ PIP4K2A P48426 2/20 0.34
▸ PIP4K2B P78356 2/20 0.34
▸ TNIK Q9UKE5 1/20 0.34
▸ PLA2G7 Q13093 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21920740 0.78 IMPDH2 (0.44) NR3C1NR3C2PGRARSLC22A12
SCHEMBL1557812 0.78 NR3C1 (0.60) NR3C1NR3C2PGRARSLC22A12
SCHEMBL30088006 0.77 XDH (0.46) SLC22A12IKBKBCHUKXDHIMPDH2
SCHEMBL28601707 0.77 XDH (0.46) SLC22A12IKBKBCHUKXDHIMPDH2
SCHEMBL28605019 0.73 XDH (0.40) NR3C1NR3C2PGRARSLC22A12
SCHEMBL2161116 0.72 NR3C1 (1.00) NR3C1NR3C2PGRARPARP14
SCHEMBL3707241 0.72 IMPDH2 (0.50) NR3C1SLC22A12IKBKBCHUKXDH
SCHEMBL28604961 0.71 XDH (0.44) SLC22A12IKBKBCHUKXDHIMPDH2
SCHEMBL30087939 0.71 XDH (0.44) SLC22A12IKBKBCHUKXDHIMPDH2
SCHEMBL7130762 0.69 ADRB3 (0.57) NR3C1NR3C2PGRARIKBKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12208088-B2 Spirocyclic 2,3-dihydro-7-azaindole compounds and uses thereof GENENTECH, INC. (US) 2025-01-28 — — US disclosed
US-20220370420-A1 SPIROCYCLIC 2,3-DIHYDRO-7-AZAINDOLE COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2022-11-24 — — US disclosed
CN-113015526-A Spirocyclic 2, 3-dihydro-7-azaindole compounds and uses thereof 豪夫迈·罗氏有限公司 2021-06-22 — — CN disclosed
WO-2020061377-A1 SPIROCYCLIC 2,3-DIHYDRO-7-AZAINDOLE COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2020-03-26 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12208088-B2 Spirocyclic 2,3-dihydro-7-azaindole compounds and uses thereof HIPK1, NEK1, HIPK2 NR3C1 397/4885NR3C2 328/4885PGR 2807/4885
US-20220370420-A1 SPIROCYCLIC 2,3-DIHYDRO-7-AZAINDOLE COMPOUNDS AND USES THEREOF HIPK1, NEK1, HIPK2 NR3C1 397/4885NR3C2 328/4885PGR 2807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback